Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.